6q8j: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,332,843 edits
m Protected "6q8j" [edit=sysop:move=sysop]
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,332,843 edits
No edit summary
Line 1: Line 1:
'''Unreleased structure'''


The entry 6q8j is ON HOLD  until Paper Publication
==Nterminal domain of human SMU1 in complex with LSP641==
<StructureSection load='6q8j' size='340' side='right'caption='[[6q8j]], [[Resolution|resolution]] 1.80&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6q8j]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6Q8J OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6Q8J FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=XS4:1-~{tert}-butyl-3-[6-(3,5-dimethoxyphenyl)-2-[[1-[1-(phenylmethyl)piperidin-4-yl]-1,2,3-triazol-4-yl]methylamino]pyrido[2,3-d]pyrimidin-7-yl]urea'>XS4</scene></td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6q8f|6q8f]], [[6q8i|6q8i]]</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6q8j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6q8j OCA], [http://pdbe.org/6q8j PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6q8j RCSB], [http://www.ebi.ac.uk/pdbsum/6q8j PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6q8j ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
New therapeutic strategies targeting influenza are actively sought due to limitations in current drugs available. Host-directed therapy is an emerging concept to target host functions involved in pathogen life cycles and/or pathogenesis, rather than pathogen components themselves. From this perspective, we focused on an essential host partner of influenza viruses, the RED-SMU1 splicing complex. Here, we identified two synthetic molecules targeting an alpha-helix/groove interface essential for RED-SMU1 complex assembly. We solved the structure of the SMU1 N-terminal domain in complex with RED or bound to one of the molecules identified to disrupt this complex. We show that these compounds inhibiting RED-SMU1 interaction also decrease endogenous RED-SMU1 levels and inhibit viral mRNA splicing and viral multiplication, while preserving cell viability. Overall, our data demonstrate the potential of RED-SMU1 destabilizing molecules as an antiviral therapy that could be active against a wide range of influenza viruses and be less prone to drug resistance.


Authors: Tengo, L., Le Corre, L., Fournier, G., Ashraf, U., Busca, P., Rameix-Welti, M.-A., Gravier-Pelletier, C., Ruigrok, R.W.H., Jacob, Y., Vidalain, P.-O., Pietrancosta, N., Naffakh, N., McCarthy, A.A., Crepin, T.
Destabilization of the human RED-SMU1 splicing complex as a basis for host-directed antiinfluenza strategy.,Ashraf U, Tengo L, Le Corre L, Fournier G, Busca P, McCarthy AA, Rameix-Welti MA, Gravier-Pelletier C, Ruigrok RWH, Jacob Y, Vidalain PO, Pietrancosta N, Crepin T, Naffakh N Proc Natl Acad Sci U S A. 2019 May 10. pii: 1901214116. doi:, 10.1073/pnas.1901214116. PMID:31076555<ref>PMID:31076555</ref>


Description: Nterminal domain of human SMU1 in complex with LSP641
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Tengo, L]]
<div class="pdbe-citations 6q8j" style="background-color:#fffaf0;"></div>
[[Category: Vidalain, P.-O]]
== References ==
[[Category: Rameix-Welti, M.-A]]
<references/>
[[Category: Jacob, Y]]
__TOC__
[[Category: Gravier-Pelletier, C]]
</StructureSection>
[[Category: Large Structures]]
[[Category: Ashraf, U]]
[[Category: Busca, P]]
[[Category: Corre, L Le]]
[[Category: Crepin, T]]
[[Category: Crepin, T]]
[[Category: Fournier, G]]
[[Category: Fournier, G]]
[[Category: Ruigrok, R.W.H]]
[[Category: Gravier-Pelletier, C]]
[[Category: Busca, P]]
[[Category: Jacob, Y]]
[[Category: McCarthy, A A]]
[[Category: Naffakh, N]]
[[Category: Naffakh, N]]
[[Category: Ashraf, U]]
[[Category: Pietrancosta, N]]
[[Category: Pietrancosta, N]]
[[Category: Le Corre, L]]
[[Category: Rameix-Welti, M A]]
[[Category: Mccarthy, A.A]]
[[Category: Ruigrok, R W.H]]
[[Category: Tengo, L]]
[[Category: Vidalain, P O]]
[[Category: Influenza virus]]
[[Category: Splicing]]
[[Category: Splicing factor]]
Retrieved from "https://proteopedia.org/6q8j"